Skip to main content

Table 1 List of mRNAs aberrantly expressed in miR-100-5p-transfected NESCs

From: hsa-miR-100-5p, an overexpressed miRNA in human ovarian endometriotic stromal cells, promotes invasion through attenuation of SMARCD1 expression

Gene family

Gene symbol

Control signal

miR-100 precursor signal

Z-score

Ratio

(A) Upregulated mRNAs

 Cytokine

CCL2

312.22

1041.65

6.87

4.32

IL11

1034.43

2782.35

5.98

3.11

LIF

128.77

261.89

3.80

2.46

RP2

838.00

1737.49

4.13

2.17

 Growth factor

BMP2

817.37

461.26

−4.41

0.45

 Peptidase

MMP1

49,499.07

74,041.18

7.47

2.40

CPXM1

70.96

120.43

2.27

2.40

 Enzyme

ASPH

1259.03

3722.52

6.99

3.81

CYBRD1

1067.64

1867.57.94

4.18

2.08

MTAP

440.73

714.19

3.88

2.18

 Transcription regulator

UBE2V1

2487.25

6026.87

5.85

2.87

SCML1

48.29

98.99

3.02

2.53

BATF3

147.71

291.50

3.05

2.02

 Transmembrane receptor

ITGA6

1383.58

2680.82

4.48

2.21

PVRL2

6699.21

13,211.87

4.72

2.04

 Transporter

ABCA1

134.70

270.47

3.29

2.12

BCAP29

1166.81

1994.48

4.09

2.03

 Other

TUBB2B

41.72

123.42

4.64

3.54

PKIA

192.01

593.66

5.84

3.20

PALM3

260.83

736.98

5.72

2.99

CEND1

196.72

412.79

4.30

2.80

EMC10

4713.79

9455.68

5.88

2.76

ERLIN2

225.65

451.23

3.82

2.41

TFPI2

752.91

1839.06

4.64

2.35

RDX

469.66

816.51

4.11

2.27

FAM131B

47.52

91.03

2.61

2.24

SWAP70

440.11

805.17

4.01

2.18

LOC728392

1643.31

3433.27

4.56

2.15

STBD1

104.93

162.95

3.20

2.15

SNRPC

10,269.42

17,744.24

4.89

2.12

 Other

CIDEC

488.37

852.48

3.68

2.05

ANGPTL4

1403.18

2829.40

4.28

2.01

 Null

LOC102723946

38.79

110.21

3.88

3.33

(B) Downregulated mRNAs

 Enzyme

HSD17B2

286.50

128.94

−5.76

0.26

PLCH1

190.28

88.66

−4.24

0.38

INMT

1404.19

713.49

−5.10

0.40

 Ion channel

KCNN2

118.10

32.10

−4.34

0.24

KCTD4

151.44

53.14

−5.41

0.28

KCTD10

1074.65

563.34

−4.14

0.47

 Kinase

FGFR3

239.75

121.71

−3.31

0.49

 Peptidase

ADAMTS5

3143.19

1023.39

−6.74

0.33

ADAM19

239.21

117.14

−3.26

0.47

 Phosphatase

LPPR4

184.80

73.50

−4.33

0.34

 Transcription regulator

SMARCD1

2210.80

932.50

−5.34

0.43

BAZ2A

288.00

135.67

−3.32

0.47

 Transporter

ATP6AP1

9337.60

3682.26

−6.29

0.40

 Other

EPDR1

3173.94

780.35

−8.19

0.27

MPZL3

125.86

59.79

−3.82

0.43

ZBED2

161.28

71.97

−3.74

0.43

SUDS3

568.38

289.31

−4.34

0.46

CGA

112.70

61.15

−3.01

0.46

TMEM30A

3229.37

1492.02

−4.80

0.47

DGCR2

4328.05

2074.04

−4.65

0.47

CTDSPL

748.62

362.73

−4.11

0.48

DEPTOR

398.87

187.27

−3.37

0.48

DNAJC11

1560.93

839.74

−3.46

0.49

CLDN11

1351.65

687.71

−3.46

0.49

 Null

SLC16A14

144.45

54.61

−3.92

0.35

PROSER2-AS1

35.66

16.12

−2.11

0.42

AREG

120.26

61.28

−3.53

0.43

  1. ABCA1 ATP-binding cassette, sub-family A, member 1; ADAM19 ADAM metallopeptidase domain 19; ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif, 5; ANGPTL4 angiopoietin-like 4 transcript variant 1; AREG amphiregulin; ASPH aspartate beta-hydroxylase, transcript variant 3; ATP6AP1 ATPase, H+ transporting, lysosomal accessory protein 1; BATF3 basic leucine zipper transcription factor, ATF-like 3; BAZ2A bromodomain adjacent to zinc finger domain, 2A; BCAP29 B-cell receptor-associated protein 29, transcript variant 2; BMP2 bone morphogenetic protein 2; CCL2 chemokine ligand 2; CEND1 cell cycle exit and neuronal differentiation 1; CGA glycoprotein hormones, alpha polypeptide, transcript variant 2; CIDEC cell death-inducing DFFA-like effector c, transcript variant 3; CLDN11 claudin 11, transcript variant 1; CPXM1 carboxypeptidase X, member 1, transcript variant 1; CTDSPL CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like, transcript variant 1; CYBRD1 cytochrome b reductase 1, transcript variant 1; DEPTOR DEP domain containing MTOR-interacting protein, transcript variant 1; DGCR2 DiGeorge syndrome critical region gene 2, transcript variant 1; DNAJC11 DnaJ (Hsp40) homolog, subfamily C, member 11; EMC10 ER membrane protein complex subunit 10, transcript variant 1; EPDR1 ependymin related 1, transcript variant 1; ERLIN2 ER lipid raft associated 2, transcript variant 1; FAM131B family with sequence similarity 131, member B, transcript variant a; FGFR3 fibroblast growth factor receptor 3, transcript variant 1; HSD17B2 hydroxysteroid (17-beta) dehydrogenase 2; IL11 interleukin 11; INMT indolethylamine N-methyltransferase, transcript variant 2; ITGA6 integrin, alpha 6, transcript variant 2; KCNN2 potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2, transcript variant 1; KCTD10 potassium channel tetramerization domain containing 10; KCTD4 potassium channel tetramerization domain containing 4; LIF leukemia inhibitory factor, transcript variant 1; LOC102723946, Zinc finger protein 695; LOC728392, uncharacterized LOC728392; LPPR4 lipid phosphate phosphatase-related protein type 4, transcript variant 1; MMP1 matrix metallopeptidase 1, transcript variant 1; MPZL3 myelin protein zero-like 3, transcript variant 1: MTAP methylthioadenosine phosphorylase; PALM3 paralemmin 3; PKIA protein kinase (cAMP-dependent, catalytic) inhibitor alpha, transcript variant 1; PLCH1 phospholipase C, eta 1, transcript variant 2; PROSER2-AS1 PROSER2 antisense RNA 1; PVRL2 poliovirus receptor-related 2, transcript variant delta; RDX radixin, transcript variant 3; RP2 retinitis pigmentosa 2; SCML1 sex comb on midleg-like 1, transcript variant 1; SLC16A14 solute carrier family 16, member 14; SMARCD1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1, transcript variant 2; SNRPC small nuclear ribonucleoprotein polypeptide C, transcript variant 1; STBD1 starch binding domain 1; SUDS3 suppressor of defective silencing 3 homolog; SWAP70 SWAP switching B-cell complex 70 kDa subunit, transcript variant 1; TFPI2 tissue factor pathway inhibitor 2, transcript variant 1; TMEM30A transmembrane protein 30A, transcript variant 1; TUBB2B tubulin, beta 2B class IIb; UBE2V1 ubiquitin-conjugating enzyme E2 variant 1, transcript variant 4; ZBED2 zinc finger, BED-type containing 2
Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us